Philadelphia University + Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

DeSimone, Joseph

< Back



Joseph A. DeSimone, Jr., MD

Contact Dr. DeSimone, Jr.

1015 Chestnut Street
Suite 1020
Philadelphia, PA 19107

(215) 955-7785
(215) 955-9362 fax

Medical School

Hahnemann University School of Medicine - 1994


Thomas Jefferson University Hospital


Thomas Jefferson University Hospital

Board Certification

Internal Medicine
Infectious Disease

Hospital Appointment

Thomas Jefferson University Hospital

Expertise & Research Interests

Dr. DeSimone is the Fellowship Director of Infectious Disease and is predominantly involved with the inpatient consultative service. He is also participating in several HIV-related clinical trials, and supervises fellows in the outpatient setting.


Most Recent Peer-Reviewed Publications

  1. Photo quiz: Fatal septicemia in an immunocompromised patient
  2. Rothia mucilaginosa prosthetic device infections: A case of prosthetic valve endocarditis
  3. Candida cerebral abscesses: A case report and review of the literature
  4. Fatal case of Weeksella virosa sepsis
  5. Clostridium septicum panophthalmitis complicated by meningitis: A case report and review of the literature
  6. Prevalence of obstructive lung disease in HIV population: A cross sectional study
  7. Osteomyelitis of the jaw: A retrospective analysis
  8. Candidemia complicated by endophthalmitis: A prospective analysis
  9. Bloodstream infections in hospitalized adults with sickle cell disease: A retrospective analysis
  10. Anti-HIV-1 microbicides - 'Chemical condoms' designed to limit the scourge of the HIV-1 pandemic
  11. Attenuation of HIV-1 infection by other microbial agents
  12. Antiretroviral therapy in the developing world
  13. Molecular Diagnostic Techniques and Other Tests for Direct Detection of HIV
  14. Successful desensitization to enfuvirtide after a hypersensitivity reaction in an HIV-1-infected man.
  15. Treatment of Mycobacterium avium Complex Immune Reconstitution Disease in HIV-1-Infected Individuals
  16. Infection of transjugular intrahepatic portosystemic shunt devices [5]
  17. Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy
  18. New methods for the detection of HIV
  19. Central nervous system infections in individuals with HIV-1 infection
  20. Tobacco use in HIV-infected women.